1.
Two Year Randomized Prospective Comparison of Ahmed Valve Versus Baerveldt Implant in Vitrectomized Eyes.
Kandarakis Stylianos A, Petrou Petros, Katsimpris Andreas, Papakonstantinou Evangelia, Timpilis Marios, Chronopoulou Konstantina et al.
J GlaucomaSep 20221 citationsRandomized Controlled Trial
Comparing Ahmed vs. Baerveldt implants in vitrectomized eyes, Baerveldt achieved lower IOP and fewer medications at 2 years, despite similar success rates and more complications, offering better IOP control.